Investor Relations

XYREC invites you to become part of its journey from start-up to scale-up and beyond. Investing in the A-Round provides XYREC the opportunity to enter the aerospace market by contracting a launching customer and filling the pipeline. The expected annual return on investment for A-Round investors exceeds 40%.

So far, XYREC has been funded by angel investors and the Dutch Government having granted an innovation credit.

For investors interested in the A-Round, please contact investor relations. contacting investor relations

http://premier-pharmacy.com/product-category/gastrointestinal/ http://healthsavy.com